14.10.20|ReutersThe company said it was expanding manufacturing capabilities for opaganib, its experimental cancer drug for which it intends to apply for emergency use in Covid-19 patients
20.10.19|Tzally GreenbergThe deal will make Ireland-headquartered Cosmo the largest shareholder of Israel-based Redhill
30.07.18|Lilach BaumerThe Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints